关注
Sarah Zohar
Sarah Zohar
在 inserm.fr 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Effect of hydrocortisone on 21-day mortality or respiratory support among critically ill patients with COVID-19: a randomized clinical trial
PF Dequin, N Heming, F Meziani, G Plantefève, G Voiriot, J Badié, ...
Jama 324 (13), 1298-1306, 2020
4952020
Phase 1 trial of a CpG oligodeoxynucleotide for patients with recurrent glioblastoma
A Carpentier, F Laigle-Donadey, S Zohar, L Capelle, A Behin, A Tibi, ...
Neuro-oncology 8 (1), 60-66, 2006
2512006
Bumetanide for the treatment of seizures in newborn babies with hypoxic ischaemic encephalopathy (NEMO): an open-label, dose finding, and feasibility phase 1/2 trial
RM Pressler, GB Boylan, N Marlow, M Blennow, C Chiron, JH Cross, ...
The Lancet Neurology 14 (5), 469-477, 2015
2412015
Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis
MC Vonk, Z Marjanovic, FHJ van den Hoogen, S Zohar, ...
Annals of the rheumatic diseases 67 (1), 98-104, 2008
2252008
Intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma: a phase II study
A Carpentier, P Metellus, R Ursu, S Zohar, F Lafitte, M Barrie, Y Meng, ...
Neuro-oncology 12 (4), 401-408, 2010
2152010
Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: early results from a French multicentre phase I–II study
D Farge, JP Marolleau, S Zohar, Z Marjanovic, J Cabane, N Mounier, ...
British journal of haematology 119 (3), 726-739, 2002
1492002
Dose‐finding study of ibuprofen in patent ductus arteriosus using the continual reassessment method
L Desfrere, S Zohar, P Morville, A Brunhes, S Chevret, G Pons, G Moriette, ...
Journal of clinical pharmacy and therapeutics 30 (2), 121-132, 2005
1462005
The continual reassessment method: comparison of Bayesian stopping rules for dose‐ranging studies
S Zohar, S Chevret
Statistics in medicine 20 (19), 2827-2843, 2001
1222001
Late morbidity after colon interposition for corrosive esophageal injury: risk factors, management, and outcome. A 20-years experience
M Chirica, N Veyrie, N Munoz-Bongrand, S Zohar, B Halimi, M Celerier, ...
Annals of surgery 252 (2), 271-280, 2010
1192010
Risk factors for conversion and complications after unilateral laparoscopic adrenalectomy
S Gaujoux, S Bonnet, M Leconte, S Zohar, J Bertherat, X Bertagna, ...
Journal of British Surgery 98 (10), 1392-1399, 2011
1032011
Efficacy and safety of bevacizumab-containing neoadjuvant therapy followed by interval debulking surgery in advanced ovarian cancer: results from the ANTHALYA trial
R Rouzier, S Gouy, F Selle, E Lambaudie, A Floquet, V Fourchotte, ...
European journal of cancer 70, 133-142, 2017
1022017
Surgery for caustic injuries of the upper gastrointestinal tract
M Chirica, M Resche-Rigon, NM Bongrand, S Zohar, B Halimi, JM Gornet, ...
Annals of surgery 256 (6), 994-1001, 2012
942012
Experimental designs for phase I and phase I/II dose-finding studies
J O'Quigley, S Zohar
British journal of cancer 94 (5), 609-613, 2006
922006
CAPE COVID Trial Group and the CRICS-TriGGERSep Network. Effect of hydrocortisone on 21-day mortality or respiratory support among critically ill patients with COVID-19: a …
PF Dequin, N Heming, F Meziani, G Plantefève, G Voiriot, J Badié, ...
JAMA 324 (13), 1298-1306, 2020
732020
Recommendations for the design of therapeutic trials for neonatal seizures
JS Soul, R Pressler, M Allen, G Boylan, H Rabe, R Portman, P Hardy, ...
Pediatric research 85 (7), 943-954, 2019
692019
Efficient adaptive designs for clinical trials of interventions for COVID-19
N Stallard, L Hampson, N Benda, W Brannath, T Burnett, T Friede, ...
Statistics in Biopharmaceutical Research 12 (4), 483-497, 2020
662020
A Bayesian dose‐finding design for drug combination clinical trials based on the logistic model
MK Riviere, Y Yuan, F Dubois, S Zohar
Pharmaceutical statistics 13 (4), 247-257, 2014
662014
A phase I dose-finding and pharmacokinetic study of subcutaneous semisynthetic homoharringtonine (ssHHT) in patients with advanced acute myeloid leukaemia
V Levy, S Zohar, C Bardin, A Vekhoff, D Chaoui, B Rio, O Legrand, ...
British journal of cancer 95 (3), 253-259, 2006
662006
Designs of drug-combination phase I trials in oncology: a systematic review of the literature
MK Riviere, C Le Tourneau, X Paoletti, F Dubois, S Zohar
Annals of Oncology 26 (4), 669-674, 2015
612015
Dose‐finding designs using a novel quasi‐continuous endpoint for multiple toxicities
M Ezzalfani, S Zohar, R Qin, SJ Mandrekar, MCL Deley
Statistics in medicine 32 (16), 2728-2746, 2013
572013
系统目前无法执行此操作,请稍后再试。
文章 1–20